Antibody-drug conjugate (ADC)

Antibody-drug conjugate (ADC) is a biologic drug designed as a targeted therapy for treating cancer. Unlike chemotherapy, ADCs are intended to target and kill tumour cells while sparing healthy cells. They represent an innovative therapeutic application that combines the targeting capabilities of monoclonal with the potent cell-killing activity of cytotoxic small molecule drugs.

Showing 1–12 of 13 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Brentuximab vedotin 12710715	CD30	Antibody-drug conjugate (ADC)	Adcetris®	5 mg/mL	–	2 mg	-80°C	2027.09	997,00 €	view product Max: 10 Min: 1 Step: 1
Enfortumab Vedotin 3PA0169	Nectin-4	Antibody-drug conjugate (ADC)	Padcev®	10 mg/mL	–	1 mg	-80 °C	2026.08	345,00 €	view product Max: 2 Min: 1 Step: 1
Enfortumab Vedotin 3PA0185	Nectin-4	Antibody-drug conjugate (ADC)	Padcev®	10 mg/mL	–	1 mg	-80 °C	2026.12	345,00 €	view product Max: 10 Min: 1 Step: 1
Gemtuzumab ozogamicin FM3513	CD33	Antibody-drug conjugate (ADC)	Mylotarg®	1 mg/mL	–	0,1 mg	-80°C	2024.08	1.161,00 €	view product Max: 10 Min: 1 Step: 1
Gemtuzumab ozogamicin GL8910	CD33	Antibody-drug conjugate (ADC)	Mylotarg®	1 mg/mL	–	0,1 mg	-80°C	2025.03	1.161,00 €	view product Max: 10 Min: 1 Step: 1
Inotuzumab Ozogamicin	CD22	Antibody-drug conjugate (ADC)	Besponsa®	0,25 mg/mL	–	0,02 mg	tba	tba	1.502,00 €	view product Max: Min: 8 Step: 1
Loncastuximab tesirine S22E015C	CD19	Antibody-drug conjugate (ADC)	Zynlonta®	5 mg/mL	–	0,5 mg	-80 °C	04/2026	1.856,00 €	view product Max: 10 Min: 1 Step: 1
Mirvetuximab soravtansine	FRɑ	Antibody-drug conjugate (ADC)	Elahere®	5 mg/mL	–	2 mg	tba	tba	1.817,00 €	view product Max: 10 Min: 8 Step: 1
Polatuzumab Vedotin B1008H10	CD79b	Antibody-drug conjugate (ADC)	Polivy®	20 mg/mL	–	1 mg	-80 °C	2024.06	552,00 €	view product Max: 6 Min: 1 Step: 1
Sacituzumab Govitecan S22L002D	Trop-2-directed ADC	Antibody-drug conjugate (ADC)	Trodelvy®	10 mg/mL	–	4 mg	-80°C	2025.08	308,00 €	view product Max: 7 Min: 1 Step: 1
Tisotumab vedotin	Tissue factor (TF)	Antibody-drug conjugate (ADC)	Tivdak®	10 mg/mL	–	1 mg	tba	tba	1.665,00 €	view product Max: 10 Min: 7 Step: 1
Trastuzumab deruxtecan 398985	HER2	Antibody-drug conjugate (ADC)	Enhertu®	20 mg/mL	–	2 mg	-80 °C	2027.05	476,00 €	view product Max: 10 Min: 1 Step: 1
Trastuzumab Emtansine B8003H02	HER2	Antibody-drug conjugate (ADC)	Kadcyla®	20 mg/mL	–	2 mg	-80 °C	2027.10	386,00 €	view product Max: 10 Min: 1 Step: 1

Not looking for Antibody-drug conjugate (ADC)?

Search our therapeutic molecules product database